Nathan W. Laney

Endocrinology
100 Central St
Chillicothe, MO 64601

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Semaglutide and Cardiovascular Outcomes in People with Type 2 Diabetes: A SUSTAIN-6 Post Hoc Analysis by Weight Loss Category.

Semaglutide and Cardiovascular Outcomes in People with Type 2 Diabetes: A SUSTAIN-6 Post Hoc Analysis by Weight Loss Category.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: February 26, 2026
Showing 1-1 of 1

Last Updated: 09/26/2026